ErlySign - Company Profile & Overview
Founded in 2019, ErlySign operates in Health Tech industry. Initially concentrating on easy-to-use cancer detection diagnostics, the company has expanded its focus to include a broader array of biotec...
Funding stage:
Pre-Series A
Last funding:
14/01/2025
Total funding:
$2.00 Mn+
Revenue:
Investors
Employee count:
14
Last 90d
14
Last 90d
FAQs on ErlySign
ErlySign was founded by Dr Deovrat Begde, Shubhendra Singh Thakur in 2019.
Health Tech startup ErlySign has raised a total funding of $2.00 million across 2 funding rounds. The last round of funding was raised on 15 January 2025. Find the details around funding rounds, participating investors, and other insights of ErlySign here...
ErlySign is a company based in Nagpur, Maharashtra, India, operating in the healthtech sector. Founded in 2019, it now employs 9 individuals. The company was established by Dr Deovrat Begde, Shubhendra Singh Thakur.
ErlySign reported revenue of ₹13.8 Lakh in FY25, an increase of 292.5% from FY24 (₹3.5 Lakh).
ErlySign is headquartered in Nagpur, India.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links